Skip to main content
All lobbying filings

AVIVA STRATEGIES (FKA MGB CONSULTING)

AVIVA STRATEGIES (FKA MGB CONSULTING) filed a Q3 termination report for TAYSHA GENE THERAPIES on October 19, 2026, reporting no lobbying activity.

Lobbying for TAYSHA GENE THERAPIES · biotechnology

All filings by AVIVA STRATEGIES (FKA MGB CONSULTING) · Everything TAYSHA GENE THERAPIES has reported

 Filing · LD-2 quarterly report Q3 terminationNo activity
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 19, 2026
Income
$20,000
What the client paid this registrant for the period.
Client based in
Texas
Representation ended
Aug 31, 2026
The registrant reported terminating its work for this client.

Official filing document

 Lobbying activity 0

No itemized activity in this filing.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem